ESSA Pharma Inc

Company Profile

ESSA Pharma Inc had its IPO on 2015-07-09 under the ticker symbol EPIX.

The company operates in the Healthcare sector and Biotechnology industry. ESSA Pharma Inc has a staff strength of 50 employees.

Stock update

Shares of ESSA Pharma Inc opened at $2.83 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.7 - $2.86, and closed at $2.74.

This is a -2.66% slip from the previous day's closing price.

A total volume of 24,444 shares were traded at the close of the day’s session.

In the last one week, shares of ESSA Pharma Inc have slipped by -6.16%.

ESSA Pharma Inc's Key Ratios

ESSA Pharma Inc has a market cap of $133.16 million, indicating a price to book ratio of 0.7885 and a price to sales ratio of 0.

In the last 12-months ESSA Pharma Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-23501624. The EBITDA ratio measures ESSA Pharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ESSA Pharma Inc’s operating margin was 0% while its return on assets stood at -11.9% with a return of equity of -17.28%.

In Q1, ESSA Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

ESSA Pharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.66 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ESSA Pharma Inc’s profitability.

ESSA Pharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 1.0089. Its price to sales ratio in the trailing 12-months stood at 0.

ESSA Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$158.50 million

Total Liabilities

$2.15 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

ESSA Pharma Inc ended 2024 with $158.50 million in total assets and $0 in total liabilities. Its intangible assets were valued at $158.50 million while shareholder equity stood at $156.34 million.

ESSA Pharma Inc ended 2024 with $0 in deferred long-term liabilities, $2.15 million in other current liabilities, 278141528.00 in common stock, $-166681137.00 in retained earnings and $0 in goodwill. Its cash balance stood at $44.30 million and cash and short-term investments were $44.30 million. The company’s total short-term debt was $125,491 while long-term debt stood at $20000.00.

ESSA Pharma Inc’s total current assets stands at $158.50 million while long-term investments were $0 and short-term investments were $112.74 million. Its net receivables were $8783.00 compared to accounts payable of $1.20 million and inventory worth $0.

In 2024, ESSA Pharma Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, ESSA Pharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.74

52-Week High

$5.215

52-Week Low

$1.4

Analyst Target Price

$19.4

ESSA Pharma Inc stock is currently trading at $2.74 per share. It touched a 52-week high of $5.215 and a 52-week low of $5.215. Analysts tracking the stock have a 12-month average target price of $19.4.

Its 50-day moving average was $2.88 and 200-day moving average was $2.93 The short ratio stood at 4.72 indicating a short percent outstanding of 0%.

Around 583.3% of the company’s stock are held by insiders while 7572.4% are held by institutions.